MY180035A - Il-1? antibodies and methods of use - Google Patents

Il-1? antibodies and methods of use

Info

Publication number
MY180035A
MY180035A MYPI2015701282A MYPI2015701282A MY180035A MY 180035 A MY180035 A MY 180035A MY PI2015701282 A MYPI2015701282 A MY PI2015701282A MY PI2015701282 A MYPI2015701282 A MY PI2015701282A MY 180035 A MY180035 A MY 180035A
Authority
MY
Malaysia
Prior art keywords
binding
antibodies
methods
receptors
antigen
Prior art date
Application number
MYPI2015701282A
Inventor
John Simard
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of MY180035A publication Critical patent/MY180035A/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Fully human monoclonal Abs includes (i) an antigen-binding variable region that exhibits very high binding affinity for IL-1? and (ii) a constant region that is effective at both activating the complement system though C1q binding and binding to several different Fc receptors.
MYPI2015701282A 2014-05-14 2009-06-01 Il-1? antibodies and methods of use MY180035A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461178350P 2014-05-14 2014-05-14
US201461057586P 2014-05-30 2014-05-30
US201461121391P 2014-12-10 2014-12-10

Publications (1)

Publication Number Publication Date
MY180035A true MY180035A (en) 2020-11-20

Family

ID=79624166

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2015701282A MY180035A (en) 2014-05-14 2009-06-01 Il-1? antibodies and methods of use

Country Status (1)

Country Link
MY (1) MY180035A (en)

Similar Documents

Publication Publication Date Title
MY154067A (en) IL-1a ABS AND METHODS OF USE
GEP20125612B (en) Prlr-specific antibody and usage thereof
EA201890907A1 (en) MUTED Fc ANTIBODIES WITH REMOVED EFFECTIVE FUNCTIONS
PE20151530A1 (en) ANTIGEN BINDING PROTEINS
NZ604003A (en) Monoclonal antibodies against her2
EA201691266A1 (en) ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION
SG195072A1 (en) Cd3-binding molecules capable of binding to human and non-human cd3
NZ608033A (en) Anti-ox40 antibodies and methods of using the same
PH12015500248A1 (en) Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
NZ597664A (en) Humanized anti-cdcp1 antibodies
MX2019014658A (en) Humanized antibodies that recognize alpha-synuclein.
IN2012DN00863A (en)
EA201790664A1 (en) ANTIBODIES AGAINST MEZOTELINE AND IMMUNOCONJUGATES
EA201070695A1 (en) MOLECULES OF HUMANIZED ANTIBODIES SPECIFIC TO IL-31
MX2015008740A (en) Human igg1 fc region variants and uses thereof.
MY147468A (en) High affinity antibodies to human il-6 receptor
IL198729A0 (en) Human monoclonal antibodies to btla and methods of use
MX2013013832A (en) Fc RECEPTOR BINDING PROTEINS.
EA201391312A1 (en) ANTIBODY TO THE HUMAN TISSUE FACTOR AND ITS APPLICATION
MX343580B (en) Antibodies against g-csfr and uses thereof.
EP3904387A4 (en) Monoclonal antibodies that bind specifically to human trbv9
WO2008091981A3 (en) Monoclonal antibody that suppresses thyrotropin receptor constitutive activity
MY180035A (en) Il-1? antibodies and methods of use
MA39078B2 (en) Anti-cd3 antibodies and methods of use
TN2013000507A1 (en) Anti-cxcr4 antibody with effector functions and its use for the treatment of cancer.